help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, M.
Right arrow Articles by Barsky, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, M.
Right arrow Articles by Barsky, S. H.

American Journal of Pathology, Vol 150, 1307-1314, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Vascular expression of E-selectin is increased in estrogen-receptor- negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha

M Nguyen, CL Corless, BM Kraling, C Tran, T Atha, J Bischoff and SH Barsky
Department of Surgery, University of California, Los Angeles 90095- 1782, USA.

Angiogenesis plays an important role in breast cancer growth and metastasis. Multiple adhesion molecules have been shown to perform critical functions in the process of angiogenesis. In this study, we analyzed 15 benign and 22 malignant estrogen-receptor-negative and estrogen-receptor-positive breast specimens for the presence of the endothelial cell adhesion molecules E-selectin and P-selectin. We found that E-selectin's expression was increased in the malignant breast tumors compared with their benign counterparts (23.86% of blood vessels versus 2.47%; P = 0.0005). Furthermore, E-selectin staining was found to be significantly increased in the estrogen-receptor-negative carcinomas compared with the estrogen-receptor-positive ones (P = 0.005). In vitro findings strongly correlated with the in vivo findings and showed a higher degree of E-selectin induction in endothelial cells exposed to conditioned media from estrogen-receptor-negative breast cancer cell lines than from estrogen-receptor-positive ones. The degree of E-selectin induction correlated with the amount of interleukin-1 alpha in the tumor-conditioned media. Neutralizing antibodies to interleukin-1 alpha significantly inhibited the E-selectin expression in endothelial cells exposed to tumor-conditioned media. The results indicate that the endothelial E-selectin expression during angiogenesis is related to breast carcinoma progression in vivo and that this component of angiogenesis may be due directly to tumor-cell-secreted interleukin-1 alpha.


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
K. L. Streicher, N. E. Willmarth, J. Garcia, J. L. Boerner, T. G. Dewey, and S. P. Ethier
Activation of a Nuclear Factor {kappa}B/Interleukin-1 Positive Feedback Loop by Amphiregulin in Human Breast Cancer Cells
Mol. Cancer Res., August 1, 2007; 5(8): 847 - 861.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. K. Stannard, R. Khurana, I. M. Evans, V. Sofra, D. I.R. Holmes, and I. Zachary
Vascular Endothelial Growth Factor Synergistically Enhances Induction of E-Selectin by Tumor Necrosis Factor-{alpha}
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 494 - 502.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Ramaswamy, A. D. Elias, N. T. Kelbick, A. Dodley, M. Morrow, M. Hauger, J. Allen, C. Rhoades, K. Kendra, H. X. Chen, et al.
Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients.
Clin. Cancer Res., May 15, 2006; 12(10): 3124 - 3129.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Lu, L. Zhang, R. S. Maul, M. R. Sartippour, A. Norris, J. Whitelegge, J. Y. Rao, and M. N. Brooks
The Novel Gene EG-1 Stimulates Cellular Proliferation
Cancer Res., July 15, 2005; 65(14): 6159 - 6166.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Yu, K. S. Moulton, M. K. Khan, S. Vineberg, E. Boye, V. M. Davis, P. E. O'Donnell, J. Bischoff, and D. S. Milstone
E-selectin is required for the antiangiogenic activity of endostatin
PNAS, May 25, 2004; 101(21): 8005 - 8010.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Zhang, R. S. Maul, J. Rao, S. Apple, D. Seligson, M. Sartippour, R. Rubio, and M. N. Brooks
Expression Pattern of the Novel Gene EG-1 in Cancer
Clin. Cancer Res., May 15, 2004; 10(10): 3504 - 3508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Niu, Z. Li, B. Peng, and P. J. Chiao
Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1{alpha} in Induction of Constitutive NF-{kappa}B Activation in Pancreatic Cancer Cells
J. Biol. Chem., April 16, 2004; 279(16): 16452 - 16462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. L. Alpaugh, J. S. Tomlinson, Y. Ye, and S. H. Barsky
Relationship of Sialyl-Lewisx/a Underexpression and E-Cadherin Overexpression in the Lymphovascular Embolus of Inflammatory Breast Carcinoma
Am. J. Pathol., August 1, 2002; 161(2): 619 - 628.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. V. Volin, J. M. Woods, M. A. Amin, M. A. Connors, L. A. Harlow, and A. E. Koch
Fractalkine: A Novel Angiogenic Chemokine in Rheumatoid Arthritis
Am. J. Pathol., October 1, 2001; 159(4): 1521 - 1530.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
T. M. Carlos
Leukocyte recruitment at sites of tumor: dissonant orchestration
J. Leukoc. Biol., August 1, 2001; 70(2): 171 - 184.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Tomlinson, S. H. Barsky, S. Nelson, S. Singer, B. Pezeshki, M. C. Lee, F. Eilber, and M. Nguyen
Different Patterns of Angiogenesis in Sarcomas and Carcinomas
Clin. Cancer Res., November 1, 1999; 5(11): 3516 - 3522.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Hebbar, F. Revillion, M.-M. Louchez, C. Fournier, J. Bonneterre, and J.-P. Peyrat
Prognostic Value of Circulating Soluble E-Selectin Concentrations in Node-negative Breast Cancer Patients
Clin. Cancer Res., June 1, 1999; 5(6): 1427 - 1433.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Luo, G. Paranya, and J. Bischoff
Noninflammatory Expression of E-Selectin Is Regulated by Cell Growth
Blood, June 1, 1999; 93(11): 3785 - 3791.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Bhat-Nakshatri, T. R. Newton, R. Goulet Jr., and H. Nakshatri
NF-kappa B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha
PNAS, June 9, 1998; 95(12): 6971 - 6976.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.